Related Experiment Video
Updated: Aug 17, 2026

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
Cardiac resynchronization therapy in patients with right bundle branch block: analysis of pooled data from the
Cesar A Egoavil1, Reginald T Ho, Arnold J Greenspon
1Thomas Jefferson University and Jefferson Heart Institute, Philadelphia, Pennsylvania 19107, USA.
Insights
Cardiac resynchronization therapy (CRT) showed limited benefits for patients with right bundle branch block (RBBB), with only New York Heart Association class improving. Further studies are needed to confirm if CRT benefits RBBB patients.
Area of Science:
- Cardiology
- Electrophysiology
Background:
- Limited inclusion of right bundle branch block (RBBB) patients in cardiac resynchronization therapy (CRT) clinical trials.
- RBBB is a specific conduction abnormality affecting ventricular depolarization.
Purpose of the Study:
- To assess the outcomes of patients with RBBB who received CRT.
- To pool data from two randomized controlled trials (MIRACLE and Contak CD) for RBBB patient analysis.
Main Methods:
- Identified 61 patients with RBBB, randomized to CRT (34) or control (27) groups.
- Analyzed baseline demographics, QRS duration, and various outcome variables at 3 and 6 months.
Main Results:
- No significant differences in baseline demographics between CRT and control groups.
- CRT patients showed improvements in NYHA class, with trends in walk distance and quality of life.
- Control group also improved in NYHA class, suggesting a potential placebo effect for objective measures.
Conclusions:
- Patients with RBBB as the qualifying wide QRS did not derive significant benefit from CRT, except for NYHA class.
- Current analysis does not support CRT use in RBBB patients, pending larger cohort studies.
- Observed improvements in control group suggest a placebo effect, complicating interpretation of CRT benefits in RBBB.
Background:
Clinical trials of cardiac resynchronization therapy (CRT) have not included many patients with right bundle branch block (RBBB).
Objectives:
We pooled data from two randomized controlled trials of CRT (Multicenter InSync Randomized Clinical Evaluation [MIRACLE] and Contak CD) in order to assess outcomes of patients with RBBB.
Methods:
A total of 61 patients with RBBB were identified, 34 of whom were randomized to the CRT group and 27 to the control group. The data from these patients were entered into a new database and analyzed.
Results:
Baseline demographics were not different between the two groups (mean age 65.5 +/- 11.3 years vs 69.5 +/- 9.6 years; male gender 91% vs 85%; patients with coronary disease 76.5% vs 88%; QRS duration 167 ms vs 164 ms; all P = NS). Outcome variables (New York Heart Association [NYHA] class, 6-minute hall walk distance, peak oxygen consumption (VO2), Minnesota Living with Heart Failure quality-of-life scores, left ventricular ejection fraction, and norepinephrine levels) were analyzed at randomization, 3 months, and 6 months.
Conclusions:
(1) With the exception of NYHA class, patients with RBBB as the qualifying wide QRS did not derive significant benefit from CRT in any of the other parameters studied at 3 or 6 months. (2) RBBB patients who received active CRT showed significant improvements in NYHA class by 6 months and trends toward improvement in 6-minute walk distance, quality-of-life scores, and norepinephrine levels. However, control patients also showed significant improvement in NYHA class by 6 months but showed no improvement in objective measurements (VO2, 6-minute walk distance, left ventricular ejection fraction, and norepinephrine levels), consistent with a placebo effect. Analysis of a larger cohort of patients with RBBB undergoing CRT may demonstrate significant benefit, but the current analysis does not support the use of CRT in patients with RBBB.
Related Concept Videos
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Pulse rhythm
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac muscle...
